title: Hybrid nanomaterials that mimic the food effect: controlling enzymatic digestion for enhanced oral drug absorption.
authors.affiliation: Ian Wark Research Institute, University of South Australia, Mawson Lakes, South Australia 5095, Australia.
authors.forename: Angel
authors.initials: A
authors.lastname: Tan
authors.forename: Amanda
authors.initials: A
authors.lastname: Martin
authors.forename: Tri-Hung
authors.initials: TH
authors.lastname: Nguyen
authors.forename: Ben J
authors.initials: BJ
authors.lastname: Boyd
authors.forename: Clive A
authors.initials: CA
authors.lastname: Prestidge
mesh_terms: D000818:Animals; D040761:Biomimetic Materials; D002214:Capsules; D000068579:Celecoxib; D051546:Cyclooxygenase 2 / Q000737:chemistry / Q000378:metabolism; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics; D004285:Dogs; D004337:Drug Carriers; D004655:Emulsions; D007408:Intestinal Absorption / Q000187:drug effects*; D008055:Lipids / Q000737:chemistry*; D008297:Male; D053758:Nanoparticles; D016062:Porosity; D011720:Pyrazoles / Q000008:administration & dosage / Q000493:pharmacokinetics; D012822:Silicon Dioxide / Q000737:chemistry*; D013449:Sulfonamides / Q000008:administration & dosage / Q000493:pharmacokinetics; D014018:Tissue Distribution
chemical_list: D002214:Capsules; D052246:Cyclooxygenase 2 Inhibitors; D004337:Drug Carriers; D004655:Emulsions; D008055:Lipids; D011720:Pyrazoles; D013449:Sulfonamides; D012822:Silicon Dioxide; D051546:Cyclooxygenase 2; D000068579:Celecoxib